Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer: a Multicentric Phase-II Randomized Trial

NCT07152067 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Liege as lead sponsor.

NCT NCT07152067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07152067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer: a Multicentric Phase-II Randomized Trial
Lead sponsor
Centre Hospitalier Universitaire de Liege
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 1, 2033
Enrollment
146 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

capra score ≤5, macroscopic tumor visualized at mri, tumor size allowing partial prostate treatment volume